Accustem Sciences ACUT
OTC ACUT
$0.13 -0.01 (-7.14%)
At close: Nov 12, 2026 · 4:00 PM EST

Accustem Sciences (ACUT) Return on Sales [ROS] (2026)

Updated

Accustem Sciences (ACUT) reported Return on Sales [ROS] of -256.68% for Q2 2026.

Analysis

Accustem Sciences (ACUT) Return on Sales [ROS] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 HCA Healthcare 105.29 Bn 103.13 Bn 17.03 Bn 15.00%
2 Natera 46.06 Bn 41.68 Bn 513.47 Mn -8.60%
3 Labcorp Holdings 30.09 Bn 28.19 Bn 1.11 Bn 10.55%
4 Quest Diagnostics 28.58 Bn 26.66 Bn 1.04 Bn 15.47%
5 Guardant Health 20.44 Bn 16.05 Bn 236.15 Mn -36.78%
6 BrightSpring Health Services 14.16 Bn 11.04 Bn 518.55 Mn 3.81%
7 Encompass Health 13.83 Bn 14.29 Bn 1.54 Bn 13.86%
8 Tempus AI 12.69 Bn 9.84 Bn 266.70 Mn -13.82%
9 Davita 11.06 Bn 9.92 Bn 1.13 Bn 13.95%
10 Accustem Sciences 2.09 Mn 2.04 Mn - -256.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -256.68%
API Access

Accustem Sciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACUT&period=max&api_key=YOUR_API_KEY